Children born to anti-Ro antibody-positive mothers do not exhibit a greater prevalence of allergic, neurodevelopmental, or autoimmune conditions.

The treatment for the cutaneous lesions is strict sun avoidance and mid to low-potency topical steroids. Systemic steroids are not required for managing cutaneous lesions. Systemic antimalarial ...

There are different types of lupus: Systemic lupus erythematosus (SLE): This is ... condition that some prescription drugs can cause. Neonatal lupus: This is a rare condition affecting infants ...

Systemic lupus erythematosus patients are at risk of ... In patients with anti-Ro and/or anti-La, cutaneous neonatal lupus is seen in approximately 5% of their offspring, whereas congenital ...

The Neonatal and Obstetrics Risks Assessment (NORA ... chronic medical conditions such as renal disease or systemic lupus erythematosus and pregnancies complicated by aneuploidy or fetal anomaly.

In a new letter, published in the Journal of the European Academy of Dermatology and Venereology, members of the lupus ...

A new study published in The Journal of the American Heart Association provides insights to improve cardiovascular disease ...

Fate Therapeutics (NASDAQ:FATE) gets FDA RMAT designation for FT819, an experimental CAR T-cell therapy for lupus. Read more ...

Recently, a new class of therapeutics that disable the neonatal Fc receptor (FcRn), which protects IgG from degradation, has emerged to treat IgG-mediated autoimmune disease. 4,5 Here, we review ...

Incurable Autoimmune Disease Systemic Lupus Erythematosus (SLE): New Genetic Findings Open Up Perspectives for Future Therapeutic Approaches Jan. 14, 2024 — Systemic lupus erythematosus (SLE ...